{
    "2019-12-09": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novartis KymriahÂ® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting",
                "features": {
                    "keywords": [
                        "Kymriah",
                        "consistent efficacy",
                        "safety outcomes",
                        "real-world setting"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Gilead (GILD) Announces Positive Long-Term Data on Yescarta",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Positive Long-Term Data",
                        "Yescarta"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}